Lipella pharmaceuticals expands its advisory board to include oncology expertise

Pittsburgh, pa., april 17, 2024 (globe newswire) -- lipella pharmaceuticals inc. (nasdaq: lipo) (“lipella” or the “company”), a clinical-stage biotechnology company, today announced the expansion of its scientific advisory board to include oncology expertise.

LIPO Ratings Summary

LIPO Quant Ranking